Trial Profile
Pulmonary Hypertension and Anastrozole Trial (PHANTOM)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2022
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms PHANTOM
- 20 Oct 2022 Status changed from active, no longer recruiting to completed.
- 03 Dec 2021 Planned End Date changed from 1 Sep 2021 to 1 Sep 2022.
- 03 Dec 2021 Planned primary completion date changed from 1 Sep 2021 to 1 Sep 2022.